CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Bank of
America Merrill Lynch 2011 Health Care Conference on Tuesday, May 10,
2011 at 4:20 p.m. Pacific Time / 7:20 p.m. Eastern Time at the Encore at
Wynn Las Vegas hotel.
A live webcast of Ironwood's presentation will be accessible through the
Investors section of the company's website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start of the presentation to
ensure adequate time for any software downloads that may be required. A
replay of the webcast will be available on Ironwood's website for 14
days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is in Phase 3 clinical
development for the treatment of irritable bowel syndrome with
constipation (IBS-C) and chronic constipation. The efficacy portion of
linaclotide's development program has been completed and will support
the NDA submission for both indications, as well as the MAA submission
for the IBS-C indication. Ironwood also has a growing pipeline of
additional drug candidates in earlier stages of development. Ironwood is
located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media